Publications by authors named "Yosuke Koroki"

Claim this Profile
C
Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.
Kazuhito Suzuki, Miku Ito, Chika Sakai, Hiroaki Tsuchiya, David Bin-Chia Wu, Yosuke Koroki

Curr Med Res Opin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINE.
Yuko Mishima, Daigo Hashimoto, Michiko Ichii, Noriko Fukuhara, Toshiki Uchida, Yosuke Koroki

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan.
Kazuhito Suzuki, Yuma Fujimori, Chika Sakai, Hiroaki Tsuchiya, Yosuke Koroki

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement.
Masako Toyosaki, Shinichiro Machida, Daisuke Tomizawa, Masaya Okada, Masashi Sawa, Yosuke Koroki

Int J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.
Yoshitaka Honma, Nobuya Monden, Keisuke Yamazaki, Satoshi Kano, Hironaga Satake, Yosuke Koroki

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in Japan.
Raf De Moor, Yosuke Koroki, David Bin-Chia Wu, Dae Young Yu, Mikiko Tohyama

BMC Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study.
Yosuke Koroki, Masataka Taguri

Target Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and outcomes in a long-term registry study of patients with high-risk metastatic hormone-naïve prostate cancer in Japan: An interim analysis of the J-ROCK study.
Hirotsugu Uemura, Rikiya Matsumoto, Atsushi Mizokami, Hideaki Miyake, Hiroji Uemura, Yosuke Koroki

Int J Urol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan.
Masaki Shiota, Raf De Moor, Yosuke Koroki, Dae Young Yu, David Bin-Chia Wu

Curr Med Res Opin· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Overall Survival with Subsequent Treatment Effect by Applying Inverse Probability of Censoring Weighting in the LATITUDE Study.
Yosuke Koroki, Masataka Taguri, Nobuaki Matsubara, Karim Fizazi

Eur Urol Open Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of abiraterone acetate plus prednisolone in patients with castration-resistant prostate cancer: a prospective, observational, post-marketing surveillance study.
Yosuke Koroki, Keiichiro Imanaka, Yukiko Yasuda, Sayuri Harada, Akiko Fujino

Jpn J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study.
Hiroji Uemura, Yosuke Koroki, Yuki Iwaki, Keiichiro Imanaka, Takeshi Kambara

BMC Urol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study.
Hiroji Uemura, Yosuke Koroki, Yuki Iwaki, Keiichiro Imanaka, Takeshi Kambara

BMC Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan.
Asuka Mori, Kohei Hashimoto, Yosuke Koroki, David Bin-Chia Wu, Naoya Masumori

Curr Med Res Opin· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis